Acquired von Willebrand disease (aVWD) is frequently observed in patients with the need for extracorporeal membrane oxygenation (ECMO). aVWD can be treated by plasma-derived concentrates containing factor VIII (FVIII) and/or von Willebrand factor (VWF) and recombinant VWF concentrate as well as adjuvant therapies such as tranexamic acid and desmopressin. However. all of these therapeu... https://www.ivoryjinelle.com/limited-value-Hunting-Camo-iPhone-SE-2nd-3rd-Gen-Pro-Case-p79729-hot-value/